The politics of harm reduction in federal prisons

被引:12
|
作者
Watson, Tara Marie [1 ]
机构
[1] Univ Toronto, Ctr Criminol & Sociolegal Studies, Toronto, ON M5S 3K9, Canada
关键词
Prisons; Harm reduction; Politics; Needle and syringe programs; INJECTION; CANADA; FACILITIES; VANCOUVER; EXCHANGE; POLICY;
D O I
10.1016/j.drugpo.2014.06.007
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: We need to understand better the political barriers to prison-based harm reduction programs. In this paper, I examine the situation in the Correctional Service of Canada (CSC), a federal prison agency with a zero-tolerance drug policy and general opposition to prison needle and syringe programs (PNSPs) and safer tattooing initiatives. Methods: This study draws on 16 interviews with former CSC senior officials, former frontline staff, and external stakeholders; CSC policy and practice documents; and testimony from a House of Commons Standing Committee public study. Thematic coding and comparison of texts were used to examine emergent themes of interest. Results: Four interrelated issues were central for understanding the political barriers: a narrower definition of harm reduction used in corrections, both in principle and practice; the Conservative government's tough-on-crime agenda; strong union opposition; and stakeholder perceptions that political constraints will likely persist, including the view that litigation may offer the only way to introduce PNSPs. Conclusion: The system is at an impasse and key questions remain about the importability of harm reduction services into federal prisons. Despite a highly challenging policy environment, moving forward will demand asking new, critical questions and devising more strategic ways of entering the political-operational dialogue that opposes evidence-based programs. (c) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:916 / 923
页数:8
相关论文
共 50 条
  • [31] FEDERAL PRISONS 1954 - US-BUR-PRISONS
    LERNER, A
    JOURNAL OF CRIMINAL LAW & CRIMINOLOGY, 1956, 46 (05): : 691 - 691
  • [32] Prisons, hepatitis C and harm minimisation
    Levy, Michael H.
    Treloar, Carla
    McDonald, Rodney M.
    Booker, Norman
    MEDICAL JOURNAL OF AUSTRALIA, 2007, 186 (12) : 647 - 649
  • [33] Correlates of public support toward federal funding for harm reduction strategies
    Magdalena Kulesza
    Bethany A. Teachman
    Alexandra J. Werntz
    Melissa L. Gasser
    Kristen P. Lindgren
    Substance Abuse Treatment, Prevention, and Policy, 10
  • [34] LESSONS FROM FEDERAL PRISONS
    SPENCER, WJ
    FORTUNE, 1980, 102 (05) : 116 - 116
  • [35] Correlates of public support toward federal funding for harm reduction strategies
    Kulesza, Magdalena
    Teachman, Bethany A.
    Werntz, Alexandra J.
    Gasser, Melissa L.
    Lindgren, Kristen P.
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2015, 10
  • [36] MEDICAL SERVICE IN FEDERAL PRISONS
    Treadway, W. L.
    PUBLIC HEALTH REPORTS, 1930, 45 (24) : 1361 - 1367
  • [37] Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment
    Fraser, Suzanne
    Moore, David
    ADDICTION RESEARCH & THEORY, 2011, 19 (04) : 375 - 379
  • [38] Review, Documentation, Assessment of Treatment, and Harm Reduction Programs of Substance Use Disorder in Iranian Prisons
    Zafarghandi, Mohammad Bagher Saberi
    Eshrati, Sahar
    Arezoomandan, Reza
    Farnia, Marziyeh
    Mohammadi, Hosein
    Vahed, Neda
    Javaheri, Arash
    Amini, Mehdi
    Heidari, Samaneh
    IRANIAN JOURNAL OF PSYCHIATRY AND CLINICAL PSYCHOLOGY, 2021, 27 (01): : 48 - 63
  • [39] "We know the streets:" race, place, and the politics of harm reduction
    Owczarzak, Jill
    Weicker, Noelle
    Urquhart, Glenna
    Morris, Miles
    Park, Ju Nyeong
    Sherman, Susan G.
    HEALTH & PLACE, 2020, 64
  • [40] French prisons and infectious risk: The urgent need to scale-up harm reduction interventions
    Michel, Laurent
    Jauffret-Roustide, Marie
    PRESSE MEDICALE, 2019, 48 (7-8): : 752 - 755